SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
Exploring ways to reduce the impact of space junk on Earth - 2The Best Portable Applications for Psychological wellness and Prosperity
- 3Examination In progress into Abuse of Japanese Government-Supported Advance
- 4Images of Bangladeshi motorcyclists sleeping at petrol pumps are AI-generated
- 5How will the universe end?
- Kids get diseases like lupus, too. As researchers hunt better treatments, this camp brings joy
- Putting resources into Yourself: Self-awareness Techniques
- Bronze Age "City of Seven Ravines" unearthed in central Asia after 3,500 years
- To fix a patient's irregular heartbeat, doctors first tested its digital 'twin'
- Why are NASA's Artemis astronauts wearing orange? What are they bringing to space? What to know about the preparation for their moon mission.
- The most effective method to Integrate Compact disc Rates into Your Retirement Arranging
- Portugal among EU countries with the most people working close to 50 hours a week
- It Shouldn’t Be Here: Rescuers Race to Save Whale Stranded in Rare Spot
- Several killed in Ukraine and Russia after cross-border attacks
